Torrent Pharmaceuticals submits ANDA for Vericiguat
Torrent Pharmaceuticals has submitted an Abbreviated New Drug Application (ANDA) for Vericiguat.
Asset / Drug
Drug and asset intelligence for Vericiguat with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.